Hypertension in pregnancy: diagnosis and management

admission to all women with pre-eclampsia, whereas others only offer it to a small proportion of women. The guidance might increase the number of women who are admitted to hospital in some centres if admission is not currently routine, but might decrease admission in other centres, thus standardising practice. Return to recommendations Monitoring and treatment of pre-eclampsia and timing of birth Recommendations 1.5.5, 1.5.7 and 1.5.12 Why the committee made the recommendations The committee updated the table from the previous guideline on the management of pregnancy with pre-eclampsia. There was limited evidence on the best place of treatment for women with pre-eclampsia. Because of this, the committee made recommendations based on other evidence they reviewed (see evidence review C), which showed that women should be admitted if there were concerns for the wellbeing of the woman or her baby, or a high risk of complications of pre-eclampsia predicted using the fullPIERS or PREP-S model. (See the section of the guideline on assessing pre-eclampsia and evidence review C for more details on the use of the fullPIERS and PREP-S models.) There was no evidence on treatment initiation thresholds or target blood pressure levels for pre-eclampsia, so the committee based their recommendations
